BioSpace News Archive

Albany NY, United States: A sphincterotome is an endoscopic surgery instrument which is employed to incise the sphincter.

DUBAI, United Arab Emirates, The global Smart Pill Boxes & Bottles market was valued at xx million US$ 144.2 Mn in 2022 and will reach xx million US$ 254.7 Mn by the end of 2028, growing at a CAGR of 9.9% during 2022-2028.

Albany NY, United States: Racehorses are trained for the racing industry. Well-known breeds for racehorses in the global racehorse industry are Thoroughbred, Arabian Horse, Quarter Horse, Standardbred, Appaloosa, Andalusian, American Miniature Horse, and Black Forest.

ViGeneron GmbH, a next-generation gene therapy company, announced a target-specific strategic collaboration and option agreement with Regeneron Pharmaceuticals Inc. to develop and commercialize a gene therapy product based on ViGeneron’s novel engineered recombinant adeno-associated virus vectors to treat an inherited retinal disease.

Nordic Nanovector ASA announces that its Nomination Committee has nominated Dr Thomas Ramdahl for election as a Non-executive Director at the Company’s Annual General Meeting on 28 April 2022.

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA -based therapeutics for patients with cardiac diseases, announced the appointment of Dr. Russell Greig, as independent Chairman of its Board of Directors.

On 5 April 2022, the Board of Directors of Nordic Nanovector ASA approved the Company’s financial statements for 2021.

IDEAYA Biosciences, Inc., a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the appointment of Catherine Mackey, Ph.D., to its Board of Directors.

MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, and KOVE Inc., announce that the MolecuLight i:X® device has successfully received regulatory clearance and is now commercially available to the wound care market in South Korea.

Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimer’s disease.